🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

8 recruiting trials

for Chronic Liver Disease (CLD)

Vitamin D2 vs Vitamin D2 Plus Calcitriol in Cholestatic Children With Vitamin D Deficiency NCT07670611Phase 41 site📍 Bangkok Chulalongkorn University · Tests: Vitamin D2, Calcitriol EUS-guided Portal Pressure Gradient (PPG) Measurement: a Potential Alternative to the Traditional HVPG NCT06863012NA1 site📍 Barcelona Fundacio Privada Mon Clinic Barcelona · Tests: Endoscopic Ultrasound-Guided Portal Pressure Gradient (EUS-PPG) Measurement, Hepatic Venous Pressure Gradient (HVPG) Me… Assessing Signatures for Fibrosis Detection in Chronic Liver Disease: A Step Beyond Conventional Biomarkers NCT07359742NA1 site📍 Brussels Universitair Ziekenhuis Brussel · Tests: Blood draw for biomarkers Safety, Efficacy and Tolerability of Bowel Preparation and Colonoscopy in Patient With CHD, CKD and CLD NCT06874036n/a1 site📍 Hyderabad Asian Institute of Gastroenterology, India · Tests: Colonoscopy Correlation Of EUS-SWQ And Liver Fibrosis Pathology In Chronic Liver Disease NCT07588854n/a1 site📍 Shanghai Shanghai General Hospital, Shanghai Jiao Tong University Sc… SSM Predicts Outcomes of CLD Inpatients With Acute Liver Injury NCT06173947n/a1 site📍 Guangzhou Nanfang Hospital, Southern Medical University · Tests: FibroScan® Expert 630 To Study the Clinical Course and Outcomes of Non-electively Hospitalised Patients of Chronic Liver Disease (CLD) With Hepatic or Extra-hepatic Predominant Organ Failure(s) at 6 Months. NCT07270809n/a1 site📍 New Delhi Institute of Liver and Biliary Sciences, India · Tests: No Intervention Phase 4, Double-blind Study Evaluating the Response on Computed Tomography (CT) Lung Density Decline Rates of Respreeza / Zemaira Weekly for 3 Years in Adults With alpha1 Antitrypsin Deficiency (AATD) NCT07326592Phase 42 sites📍 Aalborg📍 Vejle CSL Behring · Tests: CE1226
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy